Dr. Jon Daniel Wender, MD

Dr. Wender practices at West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente.

Dr. Wender's NPI, 1588811509, was assigned on August 20, 2008. Dr. Wender graduated from Albert Einstein College of Medicine in 2004. Dr. Wender's California license number on file is A94184.

Dr. Wender's primary practice is West Los Angeles Medical Center, at 6041 Cadillac Ave, Los Angeles, CA 90034 in Los Angeles County. The practice phone is (213) 857-2201.

Dr. Wender's primary practice is West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Wender to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wender practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Wender's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Wender is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Wender has a license on file in California.

Dmand AI lists conjunctivitis, laser destruction of retinal or choroid lesions and retinal occlusion among the conditions Dr. Wender treats.

CMS data shows 42 Medicare services from Dr. Wender across 2 procedure codes in 2024, for 25 Medicare patients. Medicare paid $3,084 for them. Every service was in an office.

CMS counts 25 Medicare patients who saw Dr. Wender in 2024. The largest group is 65 to 74, with 12 patients. 72% of them have diabetes, and 68% have high blood pressure. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wender's median patient age at 68, with 61% women.

In 2024, Dr. Wender wrote 465 Medicare Part D claims for 123 patients. 74% of them were for generic drugs. CMS names the drug for 429 of them, across 10 drugs with 11 or more claims each, at $20,755 in total drug cost. In 2023, CMS named 411 claims across 11 drugs.

Dr. Wender accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Wender in 2011. The most frequent topics are Vitreous Body, Cysticercosis and Eye Diseases. Dr. Wender has published most often in Ocul Immunol Inflamm. Dr. Wender's most frequent co-authors are Emmett T. Cunningham, MD, MPH, PhD, Rishi R. Doshi, MD and Robert N. Johnson, MD.

CMS Open Payments shows 5 general payments to Dr. Wender from 2 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 74% of the total. Allergan Inc. paid the most, $146.

Dmand AI lists 1 award for Dr. Wender, most recently CMS Stage 1 2012 in 2011.

Dr. Wender graduated from Albert Einstein College of Medicine in 2004.

Dr. Wender is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.